Marketing-authorisation holder · United States
Bristol-Myers Squibb Company
83 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
83 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 83
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMITID100mg | 10mg | 25mg | 50mg | 75mg · Tablet | Amitriptyline | United States | Not marketed | 1978 |
| AMNESTROGEN0.3mg | 0.625mg | 1.25mg | 2.5mg · Tablet | Conjugated estrogens, Esterified | United States | Not marketed | |
| AZACTAM IN PLASTIC CONTAINER10mg/ml | 20mg/ml | 40mg/ml · Injectable | Aztreonam | United States | Not marketed | 1989 |
| BARACLUDE0.5mg | 1mg · Tablet | Entecavir | United States | Marketed | 2005 |
| BARACLUDE0.05mg/ml · Solution | Entecavir | United States | Marketed | 2005 |
| BLENOXANE15 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Bleomycin | United States | Not marketed | 1973 |
| BUSPAR10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register de · Tablet | Buspirone | United States | Not marketed | 1986 |
| BUSPAR10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5MG **Federal Register d · Capsule | Buspirone | United States | Not marketed | 2000 |
| COUMADIN10MG | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG | 2MG | 3MG | 4MG | 5MG | 6MG | 7.5MG · Tablet | Warfarin | United States | Not marketed | 1954 |
| COUMADIN50mg/vial | 5mg/vial | 75mg/vial · Injectable | Warfarin | United States | Not marketed | 1954 |
| DAKLINZA30mg base | 60mg base | 90mg base · Tablet | Daclatasvir | United States | Not marketed | 2015 |
| DEAPRIL-ST1MG · Tablet | Ergoloid mesylates | United States | Not marketed | |
| DELALUTIN125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Hydroxyprogesterone caproate | United States | Not marketed | |
| ELIQUIS0.5mg | 2.5mg | 5mg · Tablet | Apixaban | United States | Marketed | 2012 |
| ELIQUIS0.5mg · Tablet, for suspension | Apixaban | United States | Marketed | 2012 |
| EMPLICITI300mg | 400mg · Injectable | Elotuzumab | United States | Marketed | 2015 |
| ESTRACE0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG | 2MG · Tablet | Estradiol | United States | Not marketed | 1975 |
| ETHRIL 250250mg base · Tablet | Erythromycin | United States | Not marketed | |
| ETHRIL 500500mg base · Tablet | Erythromycin | United States | Not marketed | |
| ETOPOPHOS PRESERVATIVE FREE100mg base/vial | 1gm base/vial | 500mg base/vial · Injectable | Etoposide | United States | Marketed | 1996 |
| FUNGIZONE100mg/ml · Suspension | Amphotericin b | United States | Not marketed | 1971 |
| GLUCOSCAN99m gluceptate kit n/a · Injectable | Technetium tc-99m gluceptate kit n/a | United States | Not marketed | 1978 |
| GLUCOVANCE1.25MG; 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Glibenclamide, Metformin | United States | Not marketed | 2000 |
| HALOG0.025% | 0.1% · Ointment | Halcinonide | United States | Not marketed | 1977 |
| IDHIFA100mg base | 50mg base · Tablet | Enasidenib | United States | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 83 | 83 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.